恆玄科技(688608.SH):基於公司BES2800的智能眼鏡方案已經實現量產
格隆匯7月31日丨恆玄科技(688608.SH)在互動平臺表示,公司芯片產品廣泛應用於智能可穿戴市場,包括TWS耳機、智能手錶/手環、智能眼鏡等產品。智能可穿戴市場是公司重要的戰略佈局方向,基於公司BES2800的智能眼鏡方案已經實現量產,通過全集成的音頻輸入輸出,可實現輕量化模型的本地運行,同時低功耗雙模Wi-Fi/BT可快速將部分在線語音AI需求與雲端相互響應,適配市場上主流的ISP芯片,形成帶視頻和拍照功能及圖像識別的多模態智能眼鏡系統,可實現更長佩戴時間。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.